INVO Fertility, Inc. (IVF)

Market Cap	2.98M -1.6%
Revenue (ttm)	7.53M +13.8%
Net Income	-8.76M
EPS	-33.37
Shares Out	1.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,126
Open	2.420
Previous Close	2.350
Day's Range	2.220 - 2.500
52-Week Range	1.590 - 98.000
Beta	1.60
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About IVF

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 42
• Stock Exchange: Nasdaq
• Ticker Symbol: IVF
• Website: https://www.invofertility.com

Financial Performance

In 2025, INVO Fertility's revenue was $6.84 million, an increase of 4.73% compared to the previous year's $6.53 million. Losses were -$25.13 million, 164.3% more than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 11, 2026

Data Sources Report a data error